Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:36 pm Purchase |
2024-12-31 | 13G | Iterum Therapeutics plc ITRM |
Armistice Capital, LLC | 1,445,158 4.990% |
105,158 (+7.85%) |
Filing History |
| 2024-11-14 7:54 pm Sale |
2024-09-30 | 13G | Iterum Therapeutics plc ITRM |
Point72 Asset Management, L.P. | 0 0.000% |
-850,001 (Position Closed) |
Filing History |
| 2024-11-14 3:31 pm Purchase |
2024-09-30 | 13G | Iterum Therapeutics plc ITRM |
Armistice Capital, LLC | 1,340,000 6.030% |
1,340,000 (New Position) |
Filing History |
| 2024-01-31 4:55 pm Purchase |
2024-01-30 | 13G | Iterum Therapeutics plc ITRM |
Point72 Asset Management, L.P. | 850,001 6.300% |
850,001 (New Position) |
Filing History |
| 2022-01-03 5:30 pm Sale |
2021-12-31 | 13G | Iterum Therapeutics plc ITRM |
SABBY MANAGEMENT LLC | 0 0.000% |
-516,667 (Position Closed) |
Filing History |
| 2021-02-12 5:22 pm Purchase |
2020-12-31 | 13D | Iterum Therapeutics plc ITRM |
New Leaf Venture Management III L.L.C. | 355,453 4.500% |
257,617 (+263.31%) |
Filing History |
| 2021-02-12 5:01 pm Sale |
2021-02-11 | 13D | Iterum Therapeutics plc ITRM |
Sarissa Capital Management LP | 0 0.000% |
-1,286,185 (Position Closed) |
Filing History |
| 2021-02-11 4:46 pm Sale |
2021-02-09 | 13G | Iterum Therapeutics plc ITRM |
RA Capital Management, L.P. | 0 0.000% |
-915,358 (Position Closed) |
Filing History |
| 2021-02-10 3:40 pm Purchase |
2020-07-01 | 13D | Iterum Therapeutics plc ITRM |
Advent Life Sciences LLP | 192,672 3.500% |
134,046 (+228.64%) |
Filing History |
| 2021-02-10 2:27 pm Purchase |
2021-02-10 | 13G | Iterum Therapeutics plc ITRM |
SABBY MANAGEMENT LLC | 516,667 11.000% |
516,667 (New Position) |
Filing History |
| 2021-02-09 5:02 pm Sale |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
Pivotal bioVenture Partners Fund I L.P. | 63,006 1.200% |
-0 (-0.00%) |
Filing History |
| 2021-02-08 5:16 pm Purchase |
2021-02-04 | 13G | Iterum Therapeutics plc ITRM |
RA Capital Management, L.P. | 915,358 10.600% |
248,692 (+37.30%) |
Filing History |
| 2021-02-03 2:37 pm Unchanged |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
CANAAN X L.P. | 115,545 4.000% |
0 (Unchanged) |
Filing History |
| 2021-01-29 06:32 am Sale |
2020-12-31 | 13G | Iterum Therapeutics plc ITRM |
Mitchell P. Kopin | 171,852 4.990% |
-7,802 (-4.34%) |
Filing History |
| 2020-12-02 4:31 pm Purchase |
2020-11-22 | 13G | Iterum Therapeutics plc ITRM |
RA Capital Management, L.P. | 666,667 18.900% |
666,667 (New Position) |
Filing History |
| 2020-11-23 5:02 pm Purchase |
2020-11-22 | 13D | Iterum Therapeutics plc ITRM |
Sarissa Capital Management LP | 1,286,185 30.950% |
1,286,185 (New Position) |
Filing History |
| 2020-11-10 09:02 am Unchanged |
2020-10-30 | 13G | Iterum Therapeutics plc ITRM |
WELLINGTON MANAGEMENT CO LLP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2020-11-02 06:26 am Purchase |
2020-10-22 | 13G | Iterum Therapeutics plc ITRM |
Mitchell P. Kopin | 179,654 6.800% |
179,654 (New Position) |
Filing History |
| 2020-10-29 1:00 pm Unchanged |
2020-10-27 | 13D | Iterum Therapeutics plc ITRM |
Frazier Healthcare VII L.P. | 103,811 4.200% |
0 (Unchanged) |
Filing History |
| 2020-07-10 4:19 pm Purchase |
2020-06-30 | 13G | Iterum Therapeutics plc ITRM |
Armistice Capital, LLC | 74,276 4.990% |
14,867 (+25.02%) |
Filing History |